Who Is J. Thomas Polen?
J. Thomas Polen is the President, Chief Executive Officer (CEO), and a member of the Board of Directors of Becton, Dickinson and Company (BD), one of the world’s leading medical technology companies. Under his leadership, BD continues to develop innovative medical devices, diagnostic solutions, and healthcare technologies that improve patient care worldwide.
Known for his strategic thinking and customer-focused leadership, J. Thomas Polen has helped strengthen BD’s position as a global healthcare leader. His vision is centered on innovation, digital healthcare, operational excellence, and expanding access to quality medical solutions.

Early Career and Professional Journey
J. Thomas Polen joined Becton Dickinson in 1999 and has spent more than two decades contributing to the company’s growth. During his career, he has held several senior leadership positions across different business units, gaining extensive experience in medical technology, healthcare management, and global operations.
Before becoming CEO, Polen served in multiple executive roles, where he successfully led business expansion, product innovation, and operational improvements. His deep understanding of healthcare markets prepared him to lead one of the largest medical technology companies in the world.
In 2020, he became the CEO of Becton Dickinson, taking charge during a period when the healthcare industry faced unprecedented challenges due to the COVID-19 pandemic.
About Becton Dickinson
Founded in 1897, Becton, Dickinson and Company (BD) is a global medical technology company headquartered in Franklin Lakes, New Jersey, USA.
The company develops products and services in several healthcare sectors, including:
- Medical devices
- Diagnostic systems
- Medication management
- Laboratory equipment
- Biosciences
- Infection prevention
- Digital healthcare technologies
Today, BD serves healthcare providers, hospitals, laboratories, researchers, and patients in more than 190 countries around the world.
J. Thomas Polen’s Leadership Style
One of the reasons behind Polen’s success is his collaborative leadership approach. He believes innovation happens when employees, healthcare professionals, researchers, and technology experts work together.
His leadership focuses on:
- Customer-first innovation
- Continuous improvement
- Digital transformation
- Sustainable business growth
- Employee development
- Patient safety
- Long-term healthcare impact
Rather than focusing only on short-term profits, Polen emphasizes creating long-term value for patients, healthcare providers, shareholders, and communities.
Driving Healthcare Innovation
Healthcare technology is changing rapidly, and J. Thomas Polen has positioned BD to remain at the forefront of this transformation.
Under his leadership, the company has invested in:
- Advanced diagnostic technologies
- Smart medication delivery systems
- AI-supported healthcare solutions
- Robotics and automation
- Connected healthcare devices
- Infection prevention technologies
These innovations help hospitals improve efficiency, reduce medical errors, and provide better patient outcomes.

Leading Through Global Challenges
The COVID-19 pandemic tested healthcare systems around the world. During this critical period, BD played an important role by increasing the production of medical devices, diagnostic tools, and essential healthcare products.
Polen guided the company through supply chain disruptions while ensuring healthcare providers had access to critical medical equipment. His focus on resilience, innovation, and global collaboration helped BD continue serving patients during one of the most challenging times in modern healthcare.
Business Strategy for Future Growth
J. Thomas Polen continues to focus on long-term business growth by investing in research, technology, and operational excellence.
His strategic priorities include:
- Expanding digital healthcare solutions
- Improving patient safety technologies
- Supporting healthcare professionals with advanced medical tools
- Increasing operational efficiency
- Strengthening global partnerships
- Investing in sustainable innovation
These initiatives help BD remain competitive in the fast-changing healthcare and medical technology industry.
Leadership Lessons from J. Thomas Polen
Business professionals and future leaders can learn several valuable lessons from Polen’s career:
1. Put Customers First
Successful companies solve real problems for customers rather than simply selling products.
2. Never Stop Innovating
Continuous investment in research and technology creates long-term business success.
3. Build Strong Teams
Great leaders empower employees and encourage collaboration across departments.
4. Think Long Term
Sustainable growth comes from making decisions that benefit both the business and society.
5. Adapt to Change
The healthcare industry evolves quickly, making flexibility and innovation essential for long-term success.

Why J. Thomas Polen Matters
J. Thomas Polen is recognized as one of today’s influential healthcare executives because he combines business leadership with a commitment to improving patient care. His focus on medical innovation, digital transformation, and operational excellence has strengthened Becton Dickinson’s reputation as a trusted global healthcare company.
As healthcare continues to evolve, Polen’s leadership is expected to play an important role in shaping the future of medical technology and improving healthcare outcomes worldwide.
Conclusion
J. Thomas Polen has built an impressive career through dedication, innovation, and strategic leadership. As the CEO of Becton Dickinson, he continues to guide one of the world’s most respected medical technology companies toward sustainable growth and global healthcare innovation.
His leadership demonstrates that successful businesses can achieve strong financial performance while making a meaningful difference in people’s lives. Through continuous investment in technology, patient safety, and healthcare solutions, J. Thomas Polen remains a respected figure in the global medical technology industry.

